The Biological Limits of microRNA Therapeutics: Lessons from Preclinical and Clinical Studies
Preprint
- 17 July 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression through post-transcriptional gene silencing. Since their discovery, miRNAs have emerged as key regulators of numerous biological processes and have been implicated in a wide range of human diseases, including liver cancer. Altered miRNA expression profiles have been associated with disease initiation, progression, therapeutic response, and clinical outcome, including in chronic liver diseases and hepatocellular carcinoma, where numerous dysregulated miRNAs have been proposed as therapeutic targets. Consequently, considerable efforts have focused on restoring downregulated tumor suppressor miRNAs using synthetic mimics or inhibiting oncogenic miRNAs with antisense oligonucleotides and related technologies. Despite encouraging preclinical results and substantial investment over the past two decades, the clinical translation of miRNA-based therapeutics has remained limited.In this review, we examine the biological and translational challenges that inherently limit therapeutic modulation of miRNAs in vivo. We discuss how the broad regulatory scope of individual miRNAs, their extensive target networks, context-dependent functions, functional redundancy, and the difficulty of achieving physiologically relevant modulation contribute to unpredictable therapeutic outcomes. Collectively, the available data suggests that although miRNAs remain invaluable biomarkers and powerful tools for understanding disease biology, the very biological properties that make them attractive regulators of cellular processes also represent fundamental challenges to their successful therapeutic application.Keywords
All Related Versions
This publication has 52 references indexed in Scilit:
- The asialoglycoprotein receptor suppresses the metastasis of hepatocellular carcinoma via LASS2-mediated inhibition of V-ATPase activityCancer Letters, 2016
- microRNA-103/107 Family Regulates Multiple Epithelial Stem Cell CharacteristicsStem Cells, 2015
- microRNA-21 mediates epithelial-mesenchymal transition of human hepatocytes via PTEN/Akt pathwayBiomedicine & Pharmacotherapy, 2015
- MiR-29b inhibits collagen maturation in hepatic stellate cells through down-regulating the expression of HSP47 and lysyl oxidaseBiochemical and Biophysical Research Communications, 2014
- Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosisHepatology, 2010
- Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer ModelCell, 2009
- miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cellsCancer Letters, 2009
- Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expressionHepatology, 2008
- Targeted Deletion Reveals Essential and Overlapping Functions of the miR-17∼92 Family of miRNA ClustersCell, 2008
- miR-122 regulation of lipid metabolism revealed by in vivo antisense targetingCell Metabolism, 2006